CA2812635A1

Electrospun silk material systems for wound healing

Abstract

The present invention relates to the processes of preparing silkfibroin/polyethylene oxide blended materials, and the resulting materials thereof, which are suitable for biomedical applications such as wound healing. In particular, the electrospun silk fibroin/PEO mats with a silk:PEO blend ratio of 2:1 to 4:1, treated with controlled evaporation, constraint-drying techniques, and/or alcohol treatment, and/or PEO extraction, demonstrate suitable physical and biofunctional properties, such as fiber structure, topography, absorption, water vapor transmission rates, oxygen permeation, and biodegradability, relevant to biomaterial systems with utility for wound dressings.

CA2812635A1, drawing sheet 1
Sheet 1 of 27

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

33 claims: 14 independent, 19 dependent

  1. 1
    CA 02812635 2013-01-09 WO 2011/008842 PCT/US2010/041953 CLAIMS What is claimed is:1. A process for producing a silk mat, comprising: blending a polyethylene oxide (PEO) with an aqueous silk fibroin solution;electro spinning the blended solution, thereby forming a silk protein/PEO blended mat;and constraint-drying the electrospun silk mat.
  2. 4
    The process as in any one of claims 1-3, further comprising embedding at least one active agent in the silk mat.
  3. 9
    A silk material prepared from the process comprising:blending a polyethylene oxide (PEO) with an aqueous silk fibroin solution;electro spinning the blended solution, thereby forming a silk protein/PEO blend mat;and constraint-drying the electrospun silk mat.
  4. 10
    A silk material encapsulating at least one active agent for dressing a wound to promote wound healing prepared from the process comprising:blending a polyethylene oxide (PEO) with an aqueous silk fibroin solution comprising at least one active agent;electro spinning the blended solution, thereby forming a silk protein/PEO blend mat encapsulating the active agent(s);and constraint-drying the electrospun silk mat encapsulating the active agent(s).
  5. 15
    The silk material as in any one of claims 9 to 14, wherein the electrospun silk mat is further treated with alcohol.
  6. 16
    The silk material as in any one of claims 9 to 15, wherein the PEO is extracted from the electrospun silk mat.
  7. 17
    An electrospun silk material comprising a silk fibroin protein ranging from about 50 wt % to about 100 wt %, wherein the electrospun silk mat has a thickness of about 20 microns to 80 about microns.
  8. 21
    The silk material as in any one of claims 17 to 20, further comprising at least one active agent.
  9. 23
    The silk material as in any one of claims 17 to 22, wherein the silk mat has a thickness of about 20-30 microns.
  10. 24
    The silk material as in any one of claims 17 to 23, wherein the silk mats have interconnected pores with the pore throat size surface area averaging from about 0.1 to about 0.3 microns.
  11. 29
    A method of promoting wound healing comprising contacting a wound with at least one electrospun silk mat comprising a silk fibroin protein and, optionally, at least one active agent;wherein the silk fibroin protein ranges from about 50 wt% to about 90 wt%, wherein the silk mat has a thickness of about 20 micron to about 80 micron;wherein the silk mat has a water absorption content of more than about 460 %, or equilibrium water content more than about 82%;and wherein the resulting silk mat has an oxygen transmission rate of more than about 15460 cm3/m2/day.
  12. 31
    A method of promoting wound healing comprising contacting a wound with at least one electrospun silk mat comprising a silk fibroin protein, a polyethylene oxide (PEO) and, optionally, at least one active agent; wherein the silk/PEO blend ratio is from about 4:1 to about 2:1;13068123.3 CA 02812635 2013-01-09 WO 2011/008842 PCT/US2010/041953 wherein the silk mat has a thickness of about 20 micron to about 80 micron;wherein the silk mat has a water absorption content of more than about 460 %, or equilibrium water content more than about 82%;and wherein the resulting silk mat has an oxygen transmission rate of more than about 15460 cm3/m2/day.
  13. 32
    The method as in any one of claims 29 to 31, wherein said silk mat has a water vapor transmission rate of more than about 1934 g/m /day.
  14. 33
    The method as in any one of claims 29 to 32, wherein the active agent is a therapeutic agent or a biological material, selected from the group consisting of cells, proteins, peptides, nucleic acids, nucleic acid analogs, nucleotides or oligonucleotides, peptide nucleic acids, aptamers, antibodies or fragments or portions thereof, antigens or epitopes, hormones, hormone antagonists, growth factors or recombinant growth factors and fragments and variants thereof, cell attachment mediators, cytokines, enzymes, antibiotics or antimicrobial compounds, viruses toxins, prodrugs, chemotherapeutic agents, small molecules, drugs, and combinations thereof. 13068123.3